Abstract
ObjectivesCurrent standard of care for patients with stage IIIc epithelial ovarian cancer (EOC) is cytoreduction and intravenous (IV) chemotherapy. Intraperitoneal (IP) chemotherapy is considered superior to standard IV chemotherapy. Recent...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have